Overview

Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection

Status:
NOT_YET_RECRUITING
Trial end date:
2026-02-26
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to investigate the clinical efficacy and safety of a Live Biotherapeutic Product (BGY-1601-VT) intended as a first line of treatment in cases of acute vaginal infection without upfront microbiological confirmed diagnosis
Phase:
PHASE1
Details
Lead Sponsor:
NEXBIOME THERAPEUTICS